Chemodiversified Brazilin Derivatives Suppress Migration and FAK Signaling in Breast Cancer Cells
Pharmaceutical Sciences and Drug Design · 2026 · 6 (1) · 134-151
DOI: 10.51847/kgevigjpdv ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences and Drug Design, 2026. Verfasst von Wei Chen und 1 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
Breast cancer is the most frequently diagnosed malignancy in women and remains the leading cause of cancer-related mortality worldwide. The treatment of invasive forms of this disease is particularly problematic due to the toxicity and side effects associated with conventional chemotherapeutic agents. Natural products have therefore gained attention as promising candidates for anticancer drug development; among them, the homoisoflavonoid brazilin has been reported to exhibit several biological a
Zitieren
APA
Chen, W., & Zhang, L. (2026). Chemodiversified Brazilin Derivatives Suppress Migration and FAK Signaling in Breast Cancer Cells. Pharmaceutical Sciences and Drug Design, 6(1), 134-151. https://doi.org/10.51847/kgevigjpdv
Vancouver
Chen W, Zhang L. Chemodiversified Brazilin Derivatives Suppress Migration and FAK Signaling in Breast Cancer Cells. Pharmaceutical Sciences and Drug Design. 2026;6(1):134-151. doi:10.51847/kgevigjpdv
BibTeX
@article{Chen2026,
author = {Chen, Wei and Zhang, Li},
title = {Chemodiversified Brazilin Derivatives Suppress Migration and FAK Signaling in Breast Cancer Cells},
journal = {Pharmaceutical Sciences and Drug Design},
year = {2026},
volume = {6},
number = {1},
pages = {134--151},
doi = {10.51847/kgevigjpdv}
}
EUVIMED